First Bank & Trust’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $571K | Sell |
1,477
-65
| -4% | -$24.1K | 0.08% | 164 |
|
|
2026
Q1 | $451K | Buy |
1,542
+563
| +58% | +$185K | 0.07% | 164 |
|
|
2025
Q4 | $343K | Buy |
979
+212
| +28% | +$71.6K | 0.06% | 190 |
|
|
2025
Q3 | $248K | Sell |
767
-93
| -11% | -$28.9K | 0.04% | 231 |
|
|
2025
Q2 | $335K | Buy |
860
+87
| +11% | +$35K | 0.06% | 175 |
|
|
2025
Q1 | $336K | Buy |
773
+74
| +11% | +$29.7K | 0.07% | 165 |
|
|
2024
Q4 | $258K | Sell |
699
-47
| -6% | -$19.7K | 0.05% | 198 |
|
|
2024
Q3 | $388K | Buy |
746
+41
| +6% | +$21.9K | 0.07% | 156 |
|
|
2024
Q2 | $382K | Buy |
705
+17
| +2% | +$8.99K | 0.08% | 149 |
|
|
2024
Q1 | $357K | Buy |
688
+38
| +6% | +$18.9K | 0.07% | 157 |
|
|
2023
Q4 | $307K | Buy |
650
+79
| +14% | +$36.5K | 0.07% | 143 |
|
|
2023
Q3 | $249K | Hold |
571
| – | – | 0.07% | 152 |
|
|
2023
Q2 | $254K | Sell |
571
-66
| -10% | -$30.4K | 0.06% | 160 |
|
|
2023
Q1 | $293K | Sell |
637
-36
| -5% | -$17.1K | 0.08% | 146 |
|
|
2022
Q4 | $345K | Buy |
673
+20
| +3% | +$10.2K | 0.1% | 130 |
|
|
2022
Q3 | $297K | Buy |
653
+44
| +7% | +$21.1K | 0.11% | 136 |
|
|
2022
Q2 | $294K | Buy |
609
+44
| +8% | +$21.8K | 0.1% | 134 |
|
|
2022
Q1 | $278K | Buy |
565
+38
| +7% | +$17.4K | 0.09% | 148 |
|
|
2021
Q4 | $244K | Buy |
527
+13
| +3% | +$5.47K | 0.1% | 164 |
|
|
2021
Q3 | $192K | Buy |
514
+24
| +5% | +$9.12K | 0.09% | 169 |
|
|
2021
Q2 | $187K | Buy |
490
+38
| +8% | +$14.5K | 0.09% | 174 |
|
|
2021
Q1 | $162K | Buy |
452
+64
| +16% | +$20.6K | 0.08% | 187 |
|
|
2020
Q4 | $125K | Sell |
388
-17
| -4% | -$5.22K | 0.08% | 181 |
|
|
2020
Q3 | $109K | Buy |
405
+17
| +4% | +$4.57K | 0.07% | 174 |
|
|
2020
Q2 | $102K | Buy |
388
+18
| +5% | +$4.8K | 0.08% | 179 |
|
|
2020
Q1 | $84K | Sell |
370
-12
| -3% | -$3.27K | 0.08% | 182 |
|
|
2019
Q4 | $115K | Buy |
382
+22
| +6% | +$6.05K | 0.08% | 174 |
|
|
2019
Q3 | $86K | Sell |
360
-3
| -0.8% | -$822 | 0.06% | 186 |
|
|
2019
Q2 | $102K | Buy |
363
+49
| +16% | +$13.4K | 0.08% | 170 |
|
|
2019
Q1 | $90K | Sell |
314
-47
| -13% | -$13.6K | 0.07% | 184 |
|
|
2018
Q4 | $95K | Buy |
361
+50
| +16% | +$13.7K | 0.08% | 181 |
|
|
2018
Q3 | $82K | Hold |
311
| – | – | 0.06% | 190 |
|
|
2018
Q2 | $74K | Buy |
311
+95
| +44% | +$22K | 0.06% | 187 |
|
|
2018
Q1 | $47K | Hold |
216
| – | – | 0.04% | 204 |
|
|
2017
Q4 | $49K | Sell |
216
-56
| -21% | -$11.9K | 0.04% | 198 |
|
|
2017
Q3 | $52K | Sell |
272
-2
| -0.7% | -$381 | 0.04% | 192 |
|
|
2017
Q2 | $52K | Hold |
274
| – | – | 0.04% | 192 |
|
|
2017
Q1 | $45K | Buy |
274
+32
| +13% | +$5.09K | 0.04% | 198 |
|
|
2016
Q4 | $35K | Buy |
+242
| New | +$32.4K | 0.03% | 209 |
|
Other funds holding ELV
First Bank & Trust's ELV Position: Q2 2026 in Review
First Bank & Trust reduced its Elevance Health (ELV) stake by 4.2% in Q2 2026, selling an estimated $24.1K and leaving 1,477 shares worth $571K. The position accounts for 0.08% of the portfolio, ranked #164.
First Bank & Trust first reported a position in ELV in Q4 2016 and has held it in 39 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- First Bank & Trust held 1,477 shares of Elevance Health worth $571K as of Q2 2026.
- First Bank & Trust sold 65 Elevance Health shares in Q2 2026, an estimated $24.1K.
- Elevance Health made up 0.08% of First Bank & Trust's portfolio in Q2 2026, its #164 holding.
- First Bank & Trust first reported a position in Elevance Health in Q4 2016 and has held it in 39 quarters since.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on First Bank & Trust's 13F filing for Q2 2026, filed 9 Jul 2026.